title: Evidence for CGRP re-uptake in rat dura mater encephali.
abstract: OBJECTIVE
  Calcitonin gene-related peptide (CGRP) is widely distributed in the trigeminovascular system and released from sensory fibres of the cranial dura mater upon noxious stimulation. Such release may be a mechanism underlying migraine headache. Based on data from guinea pig basilar artery preparations, we have here studied CGRP release and uptake in an organ preparation of the hemisected rat skull.
  
  
  METHODS
  CGRP release from the cranial dura was quantified by a commercial enzyme-linked immunoassay. CGRP was depleted using repetitive challenges of capsaicin. After incubating the tissue with CGRP for 20 min and extensive washing, another capsaicin challenge was performed. Immunohistochemistry was used to visualize CGRP immunofluorescence in dural nerve fibres.
  
  
  RESULTS
  Capsaicin-induced CGRP release was attenuated by the transient receptor potential vanilloid receptor type I antagonist capsazepine or by Ca(2+)-free solutions. After the CGRP-depleted preparation had been exposed to exogenous CGRP, capsaicin-induced CGRP release was increased compared to the challenge just prior to incubation. CGRP uptake was not influenced by Ca(2+)-free solutions. Olcegepant and CGRP(8-37) (CGRP receptor antagonists) did not affect uptake of CGRP. However, a monoclonal CGRP-binding antibody decreased CGRP uptake significantly. Release of CGRP after incubation was attenuated by Ca(2+)-free solutions and by capsazepine. Immunohistochemical assays indicated a weak trend towards CGRP uptake in rat dura mater.
  
  
  CONCLUSIONS
  We have presented evidence for CGRP uptake in nerves and its re-release in rat dura mater. This may have implications for the pathophysiology and treatment of migraine.
authors.affiliation: Department of Neurology, Glostrup Research Institute, Glostrup Hospital, Faculty of Health Science, University of Copenhagen, Glostrup, Copenhagen, Denmark.
authors.forename: Saurabh
authors.initials: S
authors.lastname: Gupta
authors.forename: Dipak Vasantrao
authors.initials: DV
authors.lastname: Amrutkar
authors.forename: Aydin
authors.initials: A
authors.lastname: Mataji
authors.forename: Hassan
authors.initials: H
authors.lastname: Salmasi
authors.forename: Anders
authors.initials: A
authors.lastname: Hay-Schmidt
authors.forename: Majid
authors.initials: M
authors.lastname: Sheykhzade
authors.forename: Karl
authors.initials: K
authors.lastname: Messlinger
authors.forename: Jes
authors.initials: J
authors.lastname: Olesen
authors.forename: Inger
authors.initials: I
authors.lastname: Jansen-Olesen
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D015740:Calcitonin Gene-Related Peptide / Q000378:metabolism* / Q000494:pharmacology; D000077221:Calcitonin Gene-Related Peptide Receptor Antagonists; D002118:Calcium / Q000378:metabolism; D002211:Capsaicin / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors / Q000494:pharmacology; D004151:Dipeptides / Q000494:pharmacology; D004388:Dura Mater / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D010446:Peptide Fragments / Q000494:pharmacology; D010879:Piperazines; D011799:Quinazolines / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D011984:Sensory Receptor Cells / Q000187:drug effects / Q000378:metabolism*
chemical_list: D000911:Antibodies, Monoclonal; D000077221:Calcitonin Gene-Related Peptide Receptor Antagonists; D004151:Dipeptides; D010446:Peptide Fragments; D010879:Piperazines; D011799:Quinazolines; C058636:calcitonin gene-related peptide (8-37); D015740:Calcitonin Gene-Related Peptide; C071423:capsazepine; D002211:Capsaicin; D002118:Calcium; C406305:olcegepant
references.citation: Neuroscience. 2003;120(3):677-94
references.pmid: 12895509
references.citation: Cell Calcium. 2004 May;35(5):471-8
references.pmid: 15003856
references.citation: Neuroscience. 1999 Mar;89(3):901-7
references.pmid: 10199623
references.citation: Neuropharmacology. 2005 Jul;49(1):25-39
references.pmid: 15992578
references.citation: N Engl J Med. 2004 Mar 11;350(11):1104-10
references.pmid: 15014183
references.citation: Cell Mol Life Sci. 2000 May;57(5):754-78
references.pmid: 10892342
references.citation: J Physiol. 2003 Nov 1;552(Pt 3):859-67
references.pmid: 12949222
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2007 Mar;375(1):29-38
references.pmid: 17295025
references.citation: Trends Pharmacol Sci. 2000 Nov;21(11):432-8
references.pmid: 11121574
references.citation: Annu Rev Nutr. 1996;16:99-119
references.pmid: 8839921
references.citation: Acta Physiol Hung. 1987;69(3-4):481-92
references.pmid: 3661221
references.citation: Regul Pept. 1992 Jan 23;37(2):135-42
references.pmid: 1539110
references.citation: Peptides. 1999;20(2):275-84
references.pmid: 10422884
references.citation: Cephalalgia. 1996 Aug;16(5):310-6
references.pmid: 8869765
references.citation: Br J Pharmacol. 2001 Mar;132(5):1145-53
references.pmid: 11226146
references.citation: Br J Pharmacol. 2006 Jun;148(4):536-43
references.pmid: 16633354
references.citation: Can J Physiol Pharmacol. 1995 Jul;73(7):1020-4
references.pmid: 8846394
references.citation: Regul Pept. 1990 Dec 10;31(3):167-78
references.pmid: 1708899
references.citation: Br J Pharmacol. 2007 Mar;150(5):633-40
references.pmid: 17245362
references.citation: Physiol Rev. 2004 Jul;84(3):903-34
references.pmid: 15269340
references.citation: Arch Oral Biol. 1999 Jan;44(1):1-6
references.pmid: 10075144
references.citation: Neurosci Biobehav Rev. 1997 Sep;21(5):649-78
references.pmid: 9353797
references.citation: Eur J Pharmacol. 1998 Jun 12;351(1):53-9
references.pmid: 9698205
references.citation: Eur J Pharmacol. 2007 Jul 12;567(1-2):117-24
references.pmid: 17477918
references.citation: Mol Pharmacol. 2005 Sep;68(3):680-9
references.pmid: 15967874
references.citation: Neuroscience. 1989;31(2):427-38
references.pmid: 2477770
references.citation: Br J Pharmacol. 2009 Nov;158 Suppl 1:S1-254
references.pmid: 19883461
references.citation: Cephalalgia. 2002 Feb;22(1):54-61
references.pmid: 11993614
references.citation: J Comp Neurol. 2008 Mar 20;507(3):1277-99
references.pmid: 18186028
references.citation: Neurology. 2008 Apr 15;70(16):1304-12
references.pmid: 17914062
references.citation: Br J Pharmacol. 1990 Jun;100(2):312-8
references.pmid: 2379036
references.citation: Neurosci Lett. 1990 Sep 18;117(3):331-4
references.pmid: 1710041
references.citation: Proc Natl Acad Sci U S A. 1986 Aug;83(15):5731-5
references.pmid: 3488550